Statistics for Spero Therapeutics (id:8368 SPRO)

Valuation metrics

Market cap

64.88M

Enterprise value

5.19M

Trailing P/E (ttm)

14.88

Forward P/E

-1.07

PEG ratio

-1.07

Price/Sales (ttm)

0.55

Price/Book (mrq)

0.59

Enterprise Value/Revenue

0.04

Enterprise Value/EBITDA

0.25

Overview

Shares outstanding

54.52M

Float

40.47M

Shares short

625.19K

% Held by insiders

0.20%

% Held by institutions

0.23%

Average volume (10 days)

302.83K

Average volume (90 days)

Price summary

52-Week low

1.01

52-Week high

1.89

52-Week change

-0.86%

Beta

0.63

50-Day moving average

1.28

200-Day moving average

1.43

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

14.74%

Operating margin

-186.93%

Operational effectiveness

Return on assets

10.48%

Return on equity

25.80%

Income statement

Revenue (ttm)

2.22

Revenue per share (ttm)

2.22

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

31.08M

Net income to common (ttm)

17.46M

Diluted EPS (ttm)

0.08

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

63.53M

Total cash per share (mrq)

1.18

Total debt (mrq)

4.94M

Total Debt/Equity (mrq)

6.13

Current ratio (mrq)

267.80%

Book value per share (mrq)

2.02

Cash flow

Cash flow statement

-14,384,000.00

Levered free cash flow (LFCF)

1.48M